EU Medicines Agency @EMA_News@respublicae.eu
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.
Joined Apr 2022
RT @EC_HERA: On 2⃣2⃣ and 2⃣3⃣ November, HERA & @EUScienceInnov organised a multidisciplinary workshop on broad-spectrum antivirals to discuss an end-to-end approach for the development, availability and access of broad-spectrum antivirals to fight future pandemics.
Curious to learn more? 👇
EU Medicines Agency
boosted
What effects has the COVID-19 pandemic had on
🔸young people's health?
🔸non-COVID care services?
Join @SandraGallina and @OECD_Social for the launch webinar of Health at a Glance: Europe 2022
Register now!
#HealthUnion #SoHEU22
RT @OECD_Social: Join @EU_Health & @OECD_Social to launch new analysis: 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝘁 𝗮 𝗚𝗹𝗮𝗻𝗰𝗲: 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟮
Learn about the pandemic’s effect on young people's #health & non-COVID care services.
🗓️ Mon 5th Dec,…
Outbreak of #Ebola Sudan virus in Uganda: We are supporting the @WHO for rapid implementation of #clinicaltrials to establish the efficacy and safety of therapeutics and vaccines. #EMAPresser
We are in contact with developers to advance next generation monoclonal antibodies against #COVID19 based on innovative clinical study design. We will discuss this with @US_FDA and international experts in December 2022. #EMAPresser
There are high concerns that new emerging #Omicron subvariants are escaping neutralisation by available monoclonal antibody medicines against #COVID19. We will review all available data to issue new recommendations to healthcare professionals. #EMAPresser
EMA’s Emergency Task Force reviewed numerous studies which reaffirm that #COVID19vaccines are safe and provide protection for pregnant people & the babies they carry.
❗️Newborns are particularly vulnerable to the dire consequences of #COVID19 following infection. #EMAPresser
Heavy menstrual bleeding with mRNA #COVID19vaccines: our safety committee noted that most of cases appeared to be temporary & non-serious. There is no evidence showing the menstrual disorders experienced by some people have an impact on reproduction & fertility. #EMAPresser
#COVID19: EMA is contributing to international activities to advance development of mucosal vaccines that are administered via the nose, mouth or inhalation, which could increase their ability to prevent infection and to block transmission. #EMAPresser
The risk of severe #COVID19 increases exponentially if you are 60 years or older.
❗️The older you are, the more you are at risk, and vaccines can save your life.
We encourage you to get vaccinated or re-vaccinated especially if you belong to higher risk groups. #EMAPresser
📢Uptake of additional vaccine doses in last few months is rather disappointing: the European average is only 29% revaccinations in people most at risk.
❗️It is of concern that people at risk of hospitalisation or severe #COVID19 are not adequately protected. #EMAPresser
We see no major increase in #COVID19 case rates in the EU due to high immunity in population following vaccination & natural infection. However, this could change rapidly as we are getting into winter months.
❗️The virus is keeping a fast pace in its evolution. #EMAPresser
Preliminary data show that adapted #COVID19vaccines increase the neutralisation of #Omicron subvariants compared to original COVID-19 vaccines. Revaccinations with the adapted vaccines increase protection against disease. #EMAPresser
We expect to see more #COVID19vaccines that are tailored to improve the immune response against emerging #COVID19 variants. #EMAPresser
EMA's regular press briefing on public health emergencies https://nitter.eu/i/broadcasts/1jMJgLMdkEYxL
Global medicines regulators are committed to working together to combat #AntimicrobialResistance.
Read more in the ICMRA’s call to action in its joint statement: https://www.icmra.info/drupal/sites/default/files/2019-11/ICMRA_Antimicrobial_Resistance.pdf
‼️ EMA holds a regular press briefing on #PublicHealth emergencies. It will be broadcast live 🔴 today, 24 November, from 14:00 to 14:30 CET. #EMAPresser #COVID19 #monkeypox #Ebola
👉 https://www.ema.europa.eu/en/events/ema-regular-press-briefing-public-health-emergencies
#DYK that some #antibiotics are completely banned for use in animals to preserve their effectiveness in people?
Read more in the veterinary medicines regulation!
👉https://www.ema.europa.eu/en/veterinary-regulatory/overview/veterinary-medicinal-products-regulation
EMA is open to all developers of 💊💊 for the treatment or prevention of life-threatening bacterial infections. We urge companies to focus more on research and development of antimicrobials. #AntimicrobialResistance
To advance the #OneHealth agenda and illustrate the applications of technologies in areas such as:
🔶#FoodSafety
🔶omics
🔶falsified products
🔶#AnimalWelfare
Experts from @Zoetis, @EFSA_EU, @WOAH_Europe, @decide_h2020 & @vhiveAH now join the discussions at #VetBigDataForum.
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.
Joined Apr 2022
